Life science and technology companies in the Innovation Crescent™ have a myriad of resources at their disposal. Here are a few examples:

As a leading designer and builder of modular cleanroom facilities located in Suwanee, Ga., AES offers discounts to companies looking to locate their pharmaceutical or biomanufacturing operations in the Innovation Crescent. The package includes a 25 percent discount on a wide range of deliverables for a preliminary design package (compliance audit) and later discounts during the construction phase. Contact Ralph Melfi, vice president of sales and marketing at 215.393.6810, ext. 102, or for more information.

Non-profit, membership-based organization to advance the growth of Georgia’s life science industry.

A world-class membership organization educating, promoting, influencing and uniting Georgia’s technology community to foster an innovative and connected marketplace that stimulates and enhances Georgia’s tech-based economy.

Increasing internship opportunities available for students and help employers locate qualified talent in the region.

For companies looking to grow through exports.

Providing statewide leadership for the advancement and management of healthcare information and technology.

The annual public celebration of local science and technology.

Contact Us


Thank You

Thank you to the Innovation Crescent agencies of record. 

Recent Tweets

JOIN THE CONVERSATION: Thursday, April 2nd @ 10:30 AM for a review of “What We Know Right Now” regarding the new #CARESACT Paycheck Protection Program (PPP), including what #startups and small companies should know, and the actions they can take now.

Atlanta software startup raises $3.6M
Supply chain planning solutions for manufacturers and distributors, allows companies to pace their materials to actual demand in the market versus using forecasts. #supplychain @ddtechies @atlchamber via @AtlBizChron

Nearly 70 drugs and experimental compounds may be effective in treating #coronavirus. Repurposing them to treat Covid-19, may be faster than trying to invent a new antiviral from scratch.

Load More...